Precision Diagnostics of Functional and Organic Intestinal Pathology Based on Cellular and Molecular Profiling
NCT05277662 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2022-03-14
Summary
Differential diagnosis of functional and organic intestinal pathology is carried out in line with approved clinical guidelines and includes a significant list of interventions. However, considering the possibility of an "overlap" between functional and organic diseases, as well as the non-specificity of a number of assessment parameters, it is advisably to define new diagnostic approaches and reliable cell and molecular markers, that will update and ensure the precision diagnostics of intestinal diseases. The integrative functional, cell and molecular markers will create the basis and possibilities for the personalized selection of patient therapy.
The study is intended to develop the methods of precision diagnostics based on cellular-molecular profiling with an assessment of functional parameters of the intestine in functional and organic intestinal diseases.
Conditions
- Inflammatory Bowel Diseases
- Irritable Bowel Syndrome
- Healthy Volunteers
Interventions
- DIAGNOSTIC_TEST
-
cell and molecular diagnostics in accordance with functional test results
Procedure: Anorectal manometry (ARM) Studies are performed in the left lateral position with the hips and knees of the subject flexed. Manometric sensor records circumferential pressure. The base of the rectal balloon attached to the ARM catheter is sited 3-5 cm above the upper border of the anal canal, to prevent the balloon impinging upon the anal canal during inflation. The most distal recording sensor is external to anal verge. If any pain or discomfort is experienced, the probe is immediately withdrawn. Procedure: Rectal sensory test (RST) The test is also performed in the left lateral position with hips and knees flexed. Studies are conducted with either an integrated balloon on the manometric probe or with a separate system. Balloon capacity is no less than 400 mls and all components are latex-free. Insufflation is always performed with air. For ramp distension, the rate should be between 1 and 5 mL/s, and for phasic distension, inflation rate should be set at 10 mL/s (C1).
Sponsors & Collaborators
-
Moscow State University of Medicine and Dentistry
lead OTHER
Principal Investigators
-
Igor Maev, Acad.the RAS · Moscow State University of Medicine and Dentistry
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-05-15
Countries
- Russia
Study Locations
More Related Trials
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Molecular and Microbiota Signatures Underlying Colonic Diverticular Disease
NCT06764550 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson
NCT04159727 ·Status: COMPLETED ·Phase: NA
-
Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 ·Status: COMPLETED
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903 ·Status: COMPLETED
-
Gut Microbiota in Chronic GI Diseases
NCT06532110 ·Status: RECRUITING
-
A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions
NCT02822677 ·Status: COMPLETED
-
Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease
NCT06781827 ·Status: RECRUITING ·Phase: NA
-
Application of Chemical Sensors for Diagnosis of Inflammatory Bowel Diseases and Irritable Bowel Syndrome by Respiratory Samples
NCT01242163 ·Status: UNKNOWN
-
Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption
NCT01763281 ·Status: COMPLETED ·Phase: PHASE4
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation for Health Improvement (TFM3)
NCT04011943 ·Status: UNKNOWN ·Phase: NA
-
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS
NCT03675100 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for IBS
NCT05776914 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome
NCT03370614 ·Status: ACTIVE_NOT_RECRUITING
-
Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression
NCT06471894 ·Status: NOT_YET_RECRUITING
-
Exercise, Irritable Bowel Syndrome and Fibromyalgia
NCT06166563 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiome in Inflammatory Bowel Disease
NCT03589183 ·Status: RECRUITING
-
Role of Parasitic Infection in Inflammatory Bowel Disease and Irritable Bowel Syndrome
NCT04760600 ·Status: UNKNOWN
-
Cognitive Impairment and Affective Mood Disorders in Patients With IBD
NCT05760729 ·Status: UNKNOWN
-
Efficacy of the DOMINO Diet App in IBS
NCT05808036 ·Status: RECRUITING ·Phase: NA
-
Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients
NCT04340661 ·Status: TERMINATED ·Phase: NA
-
Stress and Personality Profiles in IBD
NCT02614014 ·Status: COMPLETED ·Phase: NA